- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
GE HealthCare Introduces Pristina Via Mammography System at RSNA
The new mammography system reportedly offers features that promote workflow efficiency as well as patient comfort.
Emphasizing enhanced workflow efficiency for mammography exams, GE HealthCare will unveil the Pristina Via mammography platform at the Radiological Society of North America (RSNA) conference.
In addition to offering zero-click acquisition to facilitate streamlined workflow, the Pristina Via mammography system incorporates prior image comparison, irrespective of mammography vendor, to aid in mammography assessments, according to GE HealthCare.
The Pristina Via mammography system, which will be unveiled at the RSNA conference, offers image to image cycle time for digital breast tomosynthesis (DBT) that is up to twice as fast as other mammography platforms, according to GE HealthCare. (Image courtesy of GE HealthCare.)
The company adds that the Pristina Via system offers image to image cycle time for digital breast tomosynthesis (DBT) that is up to twice as fast as other mammography platforms, as well as the lowest radiation dose for all breast thicknesses.
“Simplifying, automating, and streamlining the mammography exam to improve in-room workflows is critical to driving patient compliance and access to screening,” said John Simon, M.D., the CEO of SimonMed. “The enhancements offered by Pristina Via are part of our mission of making advanced technology accessible.”
Can AI Bolster Breast Cancer Detection in DBT Screening?
January 16th 2025In sequential breast cancer screening with digital breast tomosynthesis (DBT), true positive examinations had more than double the AI case score of true negative examinations and the highest positive AI score changes from previous exams, according to new research.
Mammography Study Suggests DBT-Based AI May Help Reduce Disparities with Breast Cancer Screening
December 13th 2024New research suggests that AI-powered assessment of digital breast tomosynthesis (DBT) for short-term breast cancer risk may help address racial disparities with detection and shortcomings of traditional mammography in women with dense breasts.
